The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories View More Recent Stories
-
Form 4 Carlyle Group Inc. For: Aug 26 Filed by: SCHWARTZ HARVEY M
-
Form 4 Carlyle Group Inc. For: Aug 26 Filed by: Ferguson Jeffrey W.
-
Form 4 Carlyle Group Inc. For: Aug 26 Filed by: Andrews Charles Elliott Jr.
-
U.S. product recalls fall in five key industries during Q2 2024
-
Redburn-Atlantic Starts The Carlyle Group LP (CG) at Buy
-
Form 144 Carlyle Group Inc. Filed by: Finn Christopher
-
Form 144 Carlyle Group Inc. Filed by: Finn Christopher
-
Hilb Group Builds on Property and Casualty Presence in Central Region
-
Advanced Auto Parts shares jump as Carlyle agrees to buy its Worldpac unit
-
Advance Auto Parts (AAP) Announces Sale of Worldpac to Carlyle (CG) for $1.5B in Cash
-
Advance Auto Parts sells Worldpac unit to Carlyle Group for $1.5 billion, cuts forecast
-
Advance Auto Parts Announces Sale of Worldpac to Carlyle for $1.5 Billion
-
General Atlantic exits India's PNB Housing in $127 million deal
-
Sciens Building Solutions Acquires San Diego-area Company
-
Midday movers:Chipotle Mexican Grill, Tencent Music fall; Starbucks rises
-
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
-
Baxter (BAX) to Divest Its Vantive Kidney Care Segment to Carlyle (CG) for $3.8 Billion
-
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
-
KBR, Inc. (KBR) Appoints Nchacha E. Etta to its Board
-
KBR Appoints Nchacha E. Etta to Board of Directors
-
Carlyle Group (CG) Explores EUR3B Sale Of Salt And Chem Producer Nobian - FT
-
Form 13F-HR Carlyle Group Inc. For: Jun 30
-
Houlihan Lokey (HLI) to Acquire Waller Helms Advisors
-
Houlihan Lokey to Acquire Waller Helms Advisors
-
Wheels Up Experience (UP) Appoints Gregory Summe to its Board
-
Wheels Up Announces Gregory Summe to Join Board of Directors
-
Sedgwick expands global marine operations to support sector's changing needs
-
Form S-8 Carlyle Group Inc.
-
Form 10-Q Carlyle Group Inc. For: Jun 30
-
Sungage Financial Announces John King as Their New Chief Financial Officer
-
The Carlyle Group LP (CG) PT Raised to $42 at TD Cowen
-
JPMorgan Downgrades The Carlyle Group LP (CG) to Neutral
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Quantum Capital to buy Cogentrix for $3 billion in bets on rising US power demand
-
The Carlyle Group (CG) to Sell Cogentrix to Quantum Capital for $3B
-
Quantum Capital Group to Acquire Cogentrix from Carlyle for $3 Billion
-
The Carlyle Group (CG) Misses Q2 EPS by 6c
-
Carlyle Secured Lending (CGBD) Announces Merger with Carlyle Secured Lending III
-
Form 8-K Carlyle Group Inc. For: Aug 05
-
Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended 2024, Declares Third Quarter 2024 Dividends of $0.47 Per Common Share and Announces Merger Agreement with Carlyle Sec
-
Carlyle Secured Lending, Inc. Announces Merger with Carlyle Secured Lending III
-
Carlyle Q2 profit misses, shares drop amid market sell-off
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Andrews Charles Elliott Jr.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Ferguson Jeffrey W.
-
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
NYC Organization of Public Service Retirees Demands Accountability following New Bill for 9/11 Funding
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work
-
Financier and Philanthropist David Rubenstein to Headline SS&C Deliver 2024 Conference
-
Piramal Pharma Limited Announces Consolidated Results for Q1FY25

